[Article Publication] Dr. Chung-Teh Lee, Teresa Huang, Ankwei Chen, Oli Wong and Sally Yang provided an update to their

August 2, 2024

Our attorneys Dr. Chung-Teh Lee, Teresa Huang, Ankwei Chen, Oli Wong and Sally Yang have updated their work on the "Pharmaceutical Intellectual Property and Competition: Taiwan" article that is published on Lexology In-Depth.  The article provides an overview of pharmaceutical product regulations in Taiwan, including the new drug approval process, the patent linkage system and the interactions with competition law.  The update for 2024 includes the new parallel review system that would allow the pharmaceutical product manufacturer to simultaneous apply for reimbursement recommendations while applying for inspection and registration of its new drug, the newly passed legislation on regenerative medicine, and the relaxing of merger filing rules for foreign enterprises setting up or operating a joint venture outside of Taiwan.

Explore the full article: https://www.lexology.com/account/activatetempaccess/?sl=2JDsGNt4YQ9CCiLqQXPs8LU1HlI



Lexology In-Depth - Pharmaceutical Intellectual Property and Competition - Taiwan

Lexology In-Depth - Pharmaceutical Intellectual Property and Competition

The contents of all materials (Content) available on the website belong to and remain with Lee, Tsai & Partners.  All rights are reserved by Lee, Tsai & Partners, and the Content may not be reproduced, downloaded, disseminated, published, or transferred in any form or by any means, except with the prior permission of Lee, Tsai & Partners.  The Content is for informational purposes only and is not offered as legal or professional advice on any particular issue or case.  The Content may not reflect the most current legal and regulatory developments.

Lee, Tsai & Partners and the editors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The contributing authors’ opinions do not represent the position of Lee, Tsai & Partners. If the reader has any suggestions or questions, please do not hesitate to contact Lee, Tsai & Partners.